These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 25885411)

  • 1. Systemic lupus erythematous and malignancy risk: a meta-analysis.
    Cao L; Tong H; Xu G; Liu P; Meng H; Wang J; Zhao X; Tang Y; Jin J
    PLoS One; 2015; 10(4):e0122964. PubMed ID: 25885411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis.
    Clarke AE; Pooley N; Marjenberg Z; Langham J; Nicholson L; Langham S; Embleton N; Wang X; Desta B; Barut V; Hammond ER
    Semin Arthritis Rheum; 2021 Dec; 51(6):1230-1241. PubMed ID: 34710720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Sjögren's syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis.
    Zhong H; Liu S; Wang Y; Xu D; Li M; Zhao Y; Zeng X
    Autoimmun Rev; 2022 May; 21(5):103084. PubMed ID: 35341972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.
    Ni J; Qiu LJ; Hu LF; Cen H; Zhang M; Wen PF; Wang XS; Pan HF; Ye DQ
    Lupus; 2014 Mar; 23(3):284-92. PubMed ID: 24429300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
    Zintzaras E; Voulgarelis M; Moutsopoulos HM
    Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Cancer in ANCA-Associated Vasculitis: A Meta-Analysis of Observational Studies.
    Shang W; Ning Y; Xu X; Li M; Guo S; Han M; Zeng R; Ge S; Xu G
    PLoS One; 2015; 10(5):e0126016. PubMed ID: 25973882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Sjogren's syndrome and malignancy risk: a systematic review and meta-analysis.
    Liang Y; Yang Z; Qin B; Zhong R
    Ann Rheum Dis; 2014 Jun; 73(6):1151-6. PubMed ID: 23687261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis.
    Song L; Wang Y; Zhang J; Song N; Xu X; Lu Y
    Arthritis Res Ther; 2018 Dec; 20(1):270. PubMed ID: 30522515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for second malignancies in mycosis fungoides: non-Hodgkin lymphoma, Hodgkin lymphoma, lung cancer, bladder cancer and melanoma.
    Goyal A; O'Leary D; Goyal K; Rubin N; Janakiram M
    J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1821-1829. PubMed ID: 34013554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family history of hematopoietic malignancy and risk of lymphoma.
    Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
    J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic lupus erythematosus is associated with increased incidence of hematologic malignancies: a meta-analysis of prospective cohort studies.
    Apor E; O'Brien J; Stephen M; Castillo JJ
    Leuk Res; 2014 Sep; 38(9):1067-71. PubMed ID: 25052307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic lupus erythematosus and malignancies risk.
    Mao S; Shen H; Zhang J
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):253-62. PubMed ID: 26319223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing cancer risk in patients with systemic lupus erythematous.
    Ladouceur A; Bernatsky S; Ramsey-Goldman R; Clarke AE
    Expert Rev Clin Immunol; 2018 Oct; 14(10):793-802. PubMed ID: 30183456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic lupus erythematous increased lung cancer risk: Evidence from a meta-analysis.
    Wu Y; Hou Q
    J Cancer Res Ther; 2016; 12(2):721-4. PubMed ID: 27461640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hodgkin's lymphoma in systemic lupus erythematosus.
    Bernatsky S; Ramsey-Goldman R; Isenberg D; Rahman A; Dooley MA; Sibley J; Boivin JF; Joseph L; Armitage J; Zoma A; Clarke A
    Rheumatology (Oxford); 2007 May; 46(5):830-2. PubMed ID: 17255135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and risk factors of infection in patients with systemic lupus erythematosus: A systematic review and meta-analysis of observational studies.
    Yuan Q; Xing X; Lu Z; Li X
    Semin Arthritis Rheum; 2020 Oct; 50(5):1022-1039. PubMed ID: 32911280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancy in systemic lupus erythematosus: what have we learned?
    Bernatsky S; Ramsey-Goldman R; Clarke AE
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):539-47. PubMed ID: 19591783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bidirectional relationship between systemic lupus erythematosus and non-Hodgkin's lymphoma: a nationwide population-based study.
    Wang LH; Wang WM; Lin SH; Shieh CC
    Rheumatology (Oxford); 2019 Jul; 58(7):1245-1249. PubMed ID: 30726952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of second malignancy after non-Hodgkin's lymphoma: a British Cohort Study.
    Mudie NY; Swerdlow AJ; Higgins CD; Smith P; Qiao Z; Hancock BW; Hoskin PJ; Linch DC
    J Clin Oncol; 2006 Apr; 24(10):1568-74. PubMed ID: 16520465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Systemic Lupus Erythematosus and Cancer Morbidity and Mortality: Findings From Cohort Studies.
    Zhang M; Wang Y; Wang Y; Bai Y; Gu D
    Front Oncol; 2022; 12():860794. PubMed ID: 35600353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.